California objects to 23andMe sale to former CEO, says it would skirt state privacy law
By Ron Leuty,
San Francisco Business Times
| 06. 16. 2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will review the deal.
In an objection filed in U.S. Bankruptcy Court in St. Louis, Bonta's team said the proposed structure of 23andMe's sale to a nonprofit formed by Wojcicki skirts a 2021 state law that would require consumers give their "separate and express" consent before their genetic data and biological samples are transferred or disclosed.
More than 20 states have opposed the sale process due to concerns that consumers' genetic information and other private data would be exposed to uses they didn't agree to when signing up for 23andMe's service. In 23andMe's home state of California, the Genetic Information Privacy Act of 2021 should empower consumers to give proactive approval to transfer their data, the filing states.
23andMe doesn't dispute that the law applies, according to the filing, but fears that compliance would be "too costly" because many Californians would...
Related Articles
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Siddhi Mahatole and Mariam E. Sunny, Reuters | 06.13.2025
Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals' (REGN.O), opens new tab offer for the DNA-testing company in a bankruptcy auction.
Last month, Regeneron agreed to...
